Junna Yamaguchi

Targeted therapy in patients with PIK3CA-related overgrowth syndrome

Quitterie Venot, Thomas Blanc, S. Hadj‐Rabia et al. · Nature · 2018 · 542 citations · Full text

Receptor Tyrosine Kinase, Pathology, Medicine +3

Sodium–glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice

Shinji Tanaka, Yuki Sugiura, Hisako Saito et al. · Kidney International · 2018 · 162 citations

Sodium–glucose Cotransporter 2, Metabolic Syndrome, Inhibition Normalizes +15

Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells.

Jun Ohsumi, Sachiko Sakakibara, Junna Yamaguchi et al. · Endocrinology · 1994 · 108 citations

Immunology, Pathology, Insulin Signaling +21

Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δ

Junna Yamaguchi, Tetsuhiro Tanaka, Nobuaki Eto et al. · Kidney International · 2015 · 87 citations · Full text

Alpelisib administration reduced lymphatic malformations in a mouse model and in patients

Florence Delestre, Quitterie Venot, Charles Bayard et al. · Science Translational Medicine · 2021 · 81 citations